Join
Live feed
·
INSIDERFilingvia Quantisnow
Coeptis Therapeutics Holdings Inc. logo

Director Cooper Kenneth Lyle converted options into 1,370 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
COEP· Coeptis Therapeutics Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track COEP (Coeptis Therapeutics Holdings Inc.) and more on Quantisnow.